According to the recent study the prefilled syringe market is projected to reach an estimated $15.0 billion by 2030 from $7.6 billion in 2023, at a CAGR of 10% from 2024 to 2030. Growth in this market is primarily driven by increasing prevalence of chronic diseases and growing home-based healthcare market.
A more than 150 page report to understand trends, opportunities and forecast in prefilled syringe market by material (glass-based and plastic-based), product type (conventional and safety), design (single chamber, dual chamber, and customized), application (anaphylaxis, diabetes, rheumatoid arthritis, and others), end user (hospitals/clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts conventional prefilled syringes will remain the largest segment, and it is also expected to witness the highest growth over the forecast period due to increasing prevalence of chronic devices like diabetes, cancer, and autoimmune diseases.
Diabetes will remain the largest application segment over the forecast due to rise in adoption of injectable devices, surges in the advantages of prefilled syringes, and an increase in prevalence of chronic diseases.
Download sample by clicking on prefilled syringe market
APAC will remain the fastest growing region over the forecast period due to improvements in healthcare infrastructure, a rise in number of hospitals equipped with advanced instruments, and development of the R&D sector.
Becton, Dickinson, and Company, Gerresheimer AG, B. Braun Melsungen, Schott AG, Baxter International, Nipro Corporation, and Shandong Weigao Group are the major suppliers in the prefilled syringe market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel’s Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056
Explore Our Latest Publications
Algal DHA and ARA Market
Broiler Farming Market
Carob Bean Gum Market
Cyolite Market
Edible Dessert Topper Market
Ethylene Oxide Adduct (EOA) Market
Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/